(844) 230-7676
LanguageThe proposed class of several thousand patients allege that Cigna and its billing contract MultiPlan violated ERISA by colluding to underpay out-of-network claims for substance use disorder treatments. As Law360…
A California federal judge ruled Cigna Health & Life Insurance Co. and MultiPlan Inc. must face claims from a proposed class of patients who allege the companies colluded to underpay…
Law360 recently published their Analysis of “Product Liability Cases To Watch: Midyear Review” Following the months long first jury opioid trial in 2021, dates for the damages trials against Teva…
Teva Pharmaceuticals on Friday said a jury verdict deeming it liable for opioid abuse in New York should be overturned because the state’s “public nuisance” theory would unleash a never-ending…
The companies “provide no legitimate basis for tossing the jury’s verdict or subjecting the court, its staff, plaintiffs and the community to a complete do-over,” the plaintiffs said. The companies’…
During the trial, the state and the Long Island counties argued that Teva’s downplaying of the risks of opioids led to communities being flooded with prescriptions, while Anda failed to…
Nassau County lawyer Hunter Shkolnik spent roughly two hours in closing arguments Monday morning, saying the remaining drugmaker defendants, all affiliated with Teva, made sales without any way to do…
Scorched by cover-up claims in nationwide opioid litigation, Endo Pharmaceuticals is hoping for heroics from a Skadden squad that is belatedly revealing vast volumes of drug marketing records, a strategy…
Teva Pharmaceuticals is scrambling to stop jurors in a New York opioid trial from viewing internal videos that transformed famous film scenes into parodies of narcotic painkiller marketing, warning that…
Thursday’s testimony came from Angela Feniger, Par’s former DEA compliance director, who is now an associate director of technical writing and quality assurance at the drugmaker. In 2010, she testified…